Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?

J Cell Physiol. 2017 Oct;232(10):2674-2678. doi: 10.1002/jcp.25796. Epub 2017 Mar 6.

Abstract

Cancer stem cells (CSCs), also called Tumor Initiating Cells (TICs), can be defined as cancer cells that are present within solid tumors or hematological cancers, which have characteristics associated with normal stem cells, but which can give rise to all cell types found in a particular cancer sample. CSCs, therefore, are transformed stem cells, which can self-renew, differentiate into diverse progenies, and drive continuous tumor growth (Kreso & Dick, , Cell Stem Cell, 14:275-291; Schatton et al., , Nature, 451:345-349; Villani, Sabbatino, Ferrone, & Ferrone, , Melanoma Management, 2:109-114; Zhou et al., , Drug Discovery, 8:806-823) (Fig. ). [Figure: see text].

Keywords: humanized mice; innate and adaptive immunity; phenotypic plasticity; tumor initiating cells.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / metabolism
  • Cell Differentiation
  • Cell Plasticity
  • Cell Proliferation
  • Humans
  • Melanoma / metabolism
  • Melanoma / pathology*
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology*
  • Phenotype
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology*

Substances

  • Biomarkers, Tumor